RICE HALL JAMES & ASSOCIATES, LLC – Revance Therapeutics, Inc. Transaction History
RICE HALL JAMES & ASSOCIATES, LLC portfolio value:
$24.21M
portfolio value
RICE HALL JAMES & ASSOCIATES, LLC quarter portfolio value change:
+95.37%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -17.38% | -188.58K shares | 9.21M | $27 | 896.75K |
| Q2 2022 | share | Decrease | -2.43% | -26.98K shares | -6.69M | $13.82 | 1.08M |
| Q1 2022 | share | Decrease | -0.15% | -1.62K shares | 3.51M | $19.5 | 1.11M |
| Q4 2021 | share | Increase | +21.11% | 194.18K shares | -7.44M | $16.49 | 1.11M |
| Q3 2021 | share | Decrease | -0.66% | -6.13K shares | -1.81M | $27.86 | 919.76K |
| Q2 2021 | share | Decrease | -16.33% | -180.65K shares | -3.48M | $29.64 | 925.89K |
| Q1 2021 | share | Decrease | -1.30% | -14.60K shares | -845K | $27.95 | 1.10M |
| Q4 2020 | share | Decrease | -0.78% | -8.86K shares | 3.36M | $28.34 | 1.12M |
| Q3 2020 | share | Increase | +9.36% | 96.73K shares | 3.17M | $25.14 | 1.13M |
| Q2 2020 | share | Increase | +0.29% | 2.99K shares | 9.98M | $24.42 | 1.03M |
| Q1 2020 | share | Decrease | -3.36% | -35.84K shares | -2.05M | $14.8 | 1.03M |
| Q4 2019 | share | Decrease | -1.17% | -12.56K shares | 3.28M | $16.23 | 1.06M |
| Q3 2019 | share | Increase | +22.19% | 195.92K shares | 2.57M | $13 | 1.07M |
| Q2 2019 | share | Increase | +654.07% | 765.70K shares | 9.60M | $12.97 | 882.76K |
| Q1 2019 | share | Increase | +252.69% | 83.87K shares | 1.17M | $15.76 | 117.06K |
| Q4 2018 | share | Increase | +36.19% | 8.82K shares | 62K | $20.13 | 33.19K |
| Q3 2018 | share | Increase | 0.00% | 24.37K shares | 606K | $24.85 | 24.37K |